These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26535788)

  • 1. Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease.
    Krishnan S; Huang J; Lee H; Guerrero A; Berglund L; Anuurad E; Lebrilla CB; Zivkovic AM
    J Proteome Res; 2015 Dec; 14(12):5109-18. PubMed ID: 26535788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.
    Natarajan P; Collier TS; Jin Z; Lyass A; Li Y; Ibrahim NE; Mukai R; McCarthy CP; Massaro JM; D'Agostino RB; Gaggin HK; Bystrom C; Penn MS; Januzzi JL
    J Am Coll Cardiol; 2019 May; 73(17):2135-2145. PubMed ID: 31047001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
    Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
    Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
    Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
    J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.
    Alwaili K; Bailey D; Awan Z; Bailey SD; Ruel I; Hafiane A; Krimbou L; Laboissiere S; Genest J
    Biochim Biophys Acta; 2012 Mar; 1821(3):405-15. PubMed ID: 21840418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.
    Agarwala AP; Rodrigues A; Risman M; McCoy M; Trindade K; Qu L; Cuchel M; Billheimer J; Rader DJ
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1515-9. PubMed ID: 25838421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
    Sattler K; Gräler M; Keul P; Weske S; Reimann CM; Jindrová H; Kleinbongard P; Sabbadini R; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
    J Am Coll Cardiol; 2015 Sep; 66(13):1470-85. PubMed ID: 26403344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.
    Sutter I; Velagapudi S; Othman A; Riwanto M; Manz J; Rohrer L; Rentsch K; Hornemann T; Landmesser U; von Eckardstein A
    Atherosclerosis; 2015 Aug; 241(2):539-46. PubMed ID: 26093887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis.
    Saku K; Zhang B; Ohta T; Arakawa K
    J Am Coll Cardiol; 1999 Feb; 33(2):436-43. PubMed ID: 9973024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
    Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
    J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study.
    Elbaz M; Faccini J; Bongard V; Ingueneau C; Taraszkiewicz D; Perret B; Ferrières J; Ruidavets JB; Vindis C
    Arch Cardiovasc Dis; 2016 Nov; 109(11):607-617. PubMed ID: 27693051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
    Krychtiuk KA; Kastl SP; Pfaffenberger S; Pongratz T; Hofbauer SL; Wonnerth A; Katsaros KM; Goliasch G; Gaspar L; Huber K; Maurer G; Dostal E; Oravec S; Wojta J; Speidl WS
    Atherosclerosis; 2014 Dec; 237(2):589-96. PubMed ID: 25463093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
    Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
    Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma high density lipoproteins and coronary artery disease.
    Sodhi HS; Lee G; Joye JA; Clifford CK; Kudchodkar BJ; Terai Y; Shaw I; Mason DT
    Adv Myocardiol; 1980; 2():513-25. PubMed ID: 7423063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling.
    Riwanto M; Rohrer L; Roschitzki B; Besler C; Mocharla P; Mueller M; Perisa D; Heinrich K; Altwegg L; von Eckardstein A; Lüscher TF; Landmesser U
    Circulation; 2013 Feb; 127(8):891-904. PubMed ID: 23349247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study [corrected].
    Schaffer A; Verdoia M; Cassetti E; Barbieri L; Perrone-Filardi P; Marino P; De Luca G
    J Thromb Thrombolysis; 2015 Jul; 40(1):61-8. PubMed ID: 25680891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin predicts coronary artery disease cardiovascular and total mortality.
    Tasevska I; Enhörning S; Persson M; Nilsson PM; Melander O
    Heart; 2016 Jan; 102(2):127-32. PubMed ID: 26661323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
    Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
    PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waist-hip ratio and low HDL predict the risk of coronary artery disease in Pakistanis.
    Nishtar S; Wierzbicki AS; Lumb PJ; Lambert-Hammill M; Turner CN; Crook MA; Mattu MA; Shahab S; Badar A; Ehsan A; Marber MS; Gill J
    Curr Med Res Opin; 2004 Jan; 20(1):55-62. PubMed ID: 14741073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.